Significant Knowledge Gains Acquired for Treating Metastatic Breast Cancer

An educational enduring online activity provided by i3 Health has provided knowledge gains pertaining to enhancing treatment tolerability, adherence, and patient-centered care for metastatic breast cancer. In the United States, breast cancer accounts for approximately 30% of cancer diagnoses among women and is the second-leading cause of cancer death. The American Cancer Society has estimated that in 2022 there will be 287,580 new cases of invasive breast cancer, with 43,250 of these cases resul...

Continue reading

How to Help Breast Cancer Survivors Become Breast Cancer Thrivers: Lillie Shockney, RN, BS, MAS, HON-ONN-CG

Lillie Shockney, RN, BS, MAS, HON-ONN-CG.

How can members of the cancer care team enable breast cancer survivors to become breast cancer thrivers? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation Medical Advisory Council, explains how to provide optimal care and support for patients with breast cancer during their treatment and beyond. 

Continue reading

Professional Oral Care for Everolimus-Induced Oral Mucositis: Naoki Niikura, MD, PhD

In combination with exemestane, everolimus is an effective treatment for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. However, this treatment can often cause oral mucositis. This serious adverse event, characterized by the formation of ulcers, can cause difficulty in swallowing and speaking, necessitating dose reduction and treatment disruption if not properly managed. In their study now published in The Oncologist, Naoki Nii...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.